Clinical Trials in Miami

Showing 7961-7980 of 11,431 trials

A Study of SYNT001 in Healthy Volunteers

NCT03643627

This study is being done to compare the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of an intravenous (IV) formulation of SYNT001. This is the first-in-human (FIH) study of SYNT001.

Healthy

Syntimmune, Inc.31 participantsStarted Aug 2016

Miami, Florida, United States

UNKNOWNPhase 2< 1 mile

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss

NCT02779192

SPI-1005 is a novel oral drug that contains a glutathione peroxidase mimetic (ebselen) that will be tested in subjects with a history of NIHL at risk for additional NIHL. The goal of this multi-center Phase 2b study is to determine whether SPI-1005 is effective in reducing an acute NIHL in this affected population. In this Phase 2b study subjects with prior NIHL will be enrolled and exposed to a calibrated sound challenge (CSC) that induces a slight acute NIHL.

Noise Induced Hearing Loss

Sound Pharmaceuticals, Incorporated180 participantsStarted Nov 2018

Miami, Florida, United States • Kansas City, Kansas, United States • Charleston, South Carolina, United States +2 more locations

COMPLETEDPhase 1< 1 mile

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

NCT00510874

The purpose of this study is to evaluate the safety and immune response of two-doses of GSK Biologicals' candidate influenza vaccine GSK 1557484A with or without adjuvant in adults. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Influenza

GlaxoSmithKline780 participantsStarted Jul 2007

Huntsville, Alabama, United States • Anaheim, California, United States • Miami, Florida, United States +7 more locations

A Study of SYNT001 in Healthy Volunteers

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

Find Trials by Condition in Miami

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Transfusion Requirements in Cardiac Surgery III

Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Caring Letters for Military Suicide Prevention

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Intermittent Auscultation Using Handheld Doppler: a Randomized Controlled Trial Comparing Perinatal Outcomes in Uganda

Building Capacity for Sustainable Livelihoods and Health

Automated Screen for Fetal Aneuploidy